AT 56Proteolysis-focusing on chimeras (PROTACs) and molecular glue degraders (MGDs) are by far the most maturely made TPD procedures. In this review, we concentrate on both preclinical experiments and scientific trials to deliver an extensive summary of the protection and clinical effectiveness of PROTACs and MGDs in hematologic malignancies over t